Discover 2,200 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,200
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: San Francisco CA, Los Angeles CA, Orange CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase1, Phase2, Recruiting
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
for
Ischemic Heart Disease (IHD),
Location: San Francisco CA, Salt Lake City UT, Houston TX,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 35 - 70+
Code: NCT06854458
Recruiting
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: San Francisco CA, Madison WI, Ann Arbor MI, Durham NC
Sponsor: Duke University
Sex: Male
Age: 18+
Code: NCT07050433
Recruiting
BID WM Digital Intervention in Aging
for
Working Memory, Inhibitory Control,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 60 - 70+
Code: NCT06918704
Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: San Francisco CA, West Valley City UT, Aurora CO,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: San Francisco CA, Los Angeles CA, Torrance CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218380
Phase3, Recruiting
A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).
for
Healthy
Location: San Francisco CA
Sponsor: Olly, PBC
Sex: Female
Age: 40 - 65
Code: NCT07033013
Recruiting
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
for
Metastatic HER2-positive Breast Cancer
Location: San Francisco CA, Glendale CA, Los Angeles CA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06435429
Phase3, Recruiting
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
for
Thyroid Cancer
Location: San Francisco CA
Sponsor: Thomas Hope
Sex: All
Age: 13+
Code: NCT06961084
Phase2, Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: San Francisco CA, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase1, Phase2, Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
for
Locally Advanced or Metastatic ER+ HER2- Breast Cancer,
Location: San Francisco CA, Los Angeles CA, Seattle WA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04606446
Phase2, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase1, Phase2, Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
for
Diabetes Mellitus, Type I
Location: San Francisco CA, Gainesville FL, Chapel Hill NC,
Sponsor: GentiBio, Inc
Sex: All
Age: 18 - 55
Code: NCT06860516
Recruiting
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors